GeneSight Testing: What Genetic Results Can and Cannot Tell You
Trying a psychiatric medication and then waiting to see whether it helps can be frustrating, especially after side effects or limited improvement. Pharmacogenomic testing is one tool clinicians may consider when reviewing medication options. GeneSight is a commercial test that examines selected genetic variations related to how the body may process or respond to certain psychiatric medications.
The important distinction: genetic results can offer useful context, but they cannot tell a clinician exactly which medication will work best for a particular person.
At a glance
GeneSight evaluates selected gene–medication relationships, not mental health diagnoses.
No genetic test can guarantee which psychiatric medication will work best.
Results should be interpreted by a clinician alongside medical history and treatment response.
What is GeneSight testing?
GeneSight Psychotropic uses a cheek-swab DNA sample to evaluate selected gene–medication relationships. Some genes influence enzymes involved in medication metabolism, which can affect how quickly certain drugs are processed. The test provides a report intended for interpretation by a prescribing clinician alongside medical history, previous treatment response, coexisting conditions, and other medications.
Pharmacogenomics is not the same as genetic testing for a mental health diagnosis. GeneSight cannot diagnose depression, anxiety, ADHD, or another psychiatric condition.
What can pharmacogenetic results help explain?
Whether certain inherited variations may affect the metabolism of selected medications.
Whether available evidence suggests a dosage consideration for a specific gene–drug combination.
Why a clinician might want closer monitoring, an alternative dose, or additional discussion when planning treatment.
How previous medication experiences might fit into a broader treatment conversation.
Evidence is stronger for some gene–drug associations than for others. For example, published Clinical Pharmacogenetics Implementation Consortium guidance addresses certain antidepressants and genes involved in drug metabolism, including CYP2D6, CYP2C19, and CYP2B6.
What GeneSight cannot tell you
It cannot predict with certainty whether a medication will improve your symptoms.
It cannot prove a psychiatric diagnosis or identify the cause of depression or anxiety.
It does not replace consideration of drug–drug interactions, medical conditions, allergies, or other safety factors.
It cannot guarantee that a medication will have no side effects or that a 'preferred' medication will be effective.
A report's color categories or interaction labels should not be interpreted as a simple instruction to start or stop a medication. Some gene–drug findings may be clinically relevant, while others have limited evidence. The FDA cautions that not all marketed drug-response predictions are established or supported for specific medicines.
Illustrative photograph — people pictured are models, not actual patients or clinic staff.
Who might benefit from discussing testing?
A clinician may consider pharmacogenetic information when someone has experienced difficult side effects, an unexpectedly strong response, or inadequate response to prior medication trials. Testing is not routinely necessary for every person starting treatment, and its value depends on the individual situation and the medications under consideration.
If you are doing well on your current regimen, a genetic report alone is generally not a reason to change it. Never adjust psychiatric medications without first discussing the risks and benefits with your prescriber.
What happens during a GeneSight test?
If testing is appropriate, a registered prescribing clinician orders it. Collection typically involves a cheek swab performed in the office or with an authorized home kit. A laboratory analyzes the sample, and the clinician reviews the report and explains whether specific results are relevant to treatment. The cost and insurance coverage can vary, so verify anticipated charges before proceeding.
How we use pharmacogenetic information at The Healed Mind Psychiatry
Our approach to psychiatric medication management begins with a complete evaluation, your treatment goals, medical and medication history, and careful follow-up. When clinically appropriate, pharmacogenetic results may be one additional source of information in shared decision-making—not a replacement for individualized clinical judgment.
Read about GeneSight Pharmacogenomic Testing and our Psychiatric Medication Management. If you would like to discuss your medication history and whether testing may be useful, schedule a psychiatric evaluation.
Have questions about medication options?
Discuss previous medication experiences with a clinician to determine whether pharmacogenetic testing may add useful information.
Frequently asked questions
Does the test show which antidepressant is best for me?
No. The report offers information about selected gene–drug interactions. Finding a suitable medication still depends on clinical factors and an individual's response.
Do I have to stop my medications before a cheek swab?
Current medication use generally does not change inherited DNA results. Do not stop medications to prepare for testing unless your own clinician gives you a separate medical instruction.
Will insurance pay for GeneSight?
Coverage and out-of-pocket costs depend on the insurer, eligibility rules, and laboratory billing policies. Ask for current cost information before the sample is processed.
Sources and further reading
This content is for educational purposes. Pharmacogenetic results require clinical interpretation and do not replace individualized evaluation or medical advice.
Image note: Photographs are illustrative and do not depict actual clinic staff or patients.
Comments